Synergy CHC Corp. (SNYR)
| Market Cap | 4.01M -75.9% |
| Revenue (ttm) | 27.70M -17.5% |
| Net Income | -15.79M |
| EPS | -1.52 |
| Shares Out | 14.90M |
| PE Ratio | n/a |
| Forward PE | 1.58 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,863,970 |
| Open | 0.2600 |
| Previous Close | 0.2782 |
| Day's Range | 0.2351 - 0.2771 |
| 52-Week Range | 0.2351 - 4.0000 |
| Beta | 0.78 |
| Analysts | Strong Buy |
| Price Target | 6.25 (+2,223.42%) |
| Earnings Date | May 14, 2026 |
About SNYR
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; Neuragen a homeopathic product; and UrgentRx, an over the counter drug. It sells its pro... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for SNYR stock is "Strong Buy." The 12-month stock price target is $6.25, which is an increase of 2,223.42% from the latest price.
News
Synergy CHC files to sell 101.71M shares of common stock for holders
17:09 EDT Synergy CHC (SNYR) files to sell 101.71M shares of common stock for holders
Synergy CHC Registration statement: Registration filing
Synergy CHC filed a registration statement on May 15, 2026, providing details about a securities offering with the SEC.
Synergy CHC Quarterly report: Q1 2026
Synergy CHC has published its Q1 2026 quarterly earnings report on May 14, 2026.
Synergy CHC Earnings release: Q1 2026
Synergy CHC released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
Synergy CHC Corp. Reports First Quarter 2026 Financial Results
N. WINDHAM, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, is announcing its financial results for the t...
Synergy CHC Proxy statement: Proxy filing
Synergy CHC filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.
Synergy CHC Proxy statement: Proxy filing
Synergy CHC filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.
Synergy CHC Proxy statement: Proxy filing
Synergy CHC filed a proxy statement on April 17, 2026, providing details for shareholder voting and corporate governance matters.
Synergy CHC reports Q4 EPS ($1.35) vs. 1c last year
Reports Q4 revenue $6.07M vs. $10.27M last year. Revenue was unfavorably impacted by the termination of a $2.9M licensing agreement. Results also reflect a $6.66M allowance for bad debt and…
Synergy CHC Earnings Call Transcript: Q4 2025
2025 saw revenue decline due to a terminated international license and several one-time charges, but strategic progress was made with a new Mexican subsidiary and strong early 2026 beverage sales. Gross margin is expected to stabilize, with growth initiatives focused on Mexico and beverages.
Synergy CHC Earnings release: Q4 2025
Synergy CHC released its Q4 2025 earnings on April 1, 2026, summarizing the period's financial results.
Synergy CHC Annual report: Q4 2025
Synergy CHC has published its Q4 2025 annual report on April 1, 2026.
Synergy CHC Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
NORTH WINDHAM, Maine, April 01, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, is announcing its financial results for ...
Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call
WESTBROOK, Maine, March 30, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced an updated date for ...
Synergy CHC Corp. Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information
WESTBROOK, Maine, March 17, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that it plans to rel...
Synergy CHC initiated with a Buy at Ascendiant
Ascendiant analyst Edward Woo initiated coverage of Synergy CHC (SNYR) with a Buy rating and $5 price target Synergy provides consumer health care, beauty, and lifestyle products, the analyst tells…
Synergy CHC expands FOCUSfactor functional across Canada
Synergy CHC (SNYR) announced a major expansion of its FOCUSfactor functional beverage portfolio across Canada, building on the successful launch of FOCUSfactor’s supplement SKUs at Walmart (WMT) Canad...
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverage Distribution Across Canada Through Walmart Canada and McKesson Canada
WESTBROOK, Maine, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced a major expansion of ...
Synergy CHC names Pedro Colmenares sales, marketing director for Mexico, LatAm
Synergy CHC (SNYR) announced that Pedro Colmenares has been appointed Director of Sales & Marketing for Mexico & Latin America. In this role, Mr. Colmenares will lead commercial strategy, market…
Synergy CHC enters new Direct Store Delivery partnerships
Synergy CHC (SNYR) announced new Direct Store Delivery partnerships with Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co. The agreements expand retail distribution of the Company’s...
Synergy CHC files $100M mixed securities shelf
16:43 EST Synergy CHC (SNYR) files $100M mixed securities shelf
Synergy CHC Registration statement: Registration Filing
Synergy CHC filed a registration statement on November 26, 2025, providing details about a securities offering with the SEC.
Synergy CHC adds five new direct store delivery partners
Synergy CHC (SNYR) announced the addition of five new Direct Store Delivery partners, expanding retail distribution of its FOCUSfactor Focus + Energy Ready-to-Drink functional beverages across Alaska,...
Synergy CHC price target lowered to $7 from $10 at Roth Capital
Roth Capital analyst Sean McGowan lowered the firm’s price target on Synergy CHC (SNYR) to $7 from $10 and keeps a Buy rating on the shares. The company made good…
Synergy CHC Earnings Call Transcript: Q3 2025
Q3 2025 saw double-digit revenue growth, higher gross margins, and continued profitability, supported by new leadership, expanded distribution, and a successful equity raise. Beverage and supplement segments both advanced, with major retail launches planned for 2026.